Innovative Thermobalancing therapy and Dr Allen’s Device for the first time employ body energy to treat chronic prostatic diseases effectively

Published on Dec 1, 2020in International Journal of Quality Innovation
· DOI :10.1186/S40887-020-00035-0
S. Allen1
Estimated H-index: 1
Sources
Abstract
Benign prostatic hyperplasia (BPH) and chronic prostatitis / chronic pelvic pain syndrome (CP/CPPS) are common chronic diseases. None of the available treatments are effective in the management of these diseases. The purpose of this study was to assess the efficacy of Thermobalancing therapy (TT) with therapeutic Dr Allen's Device (DATD) for the treatment of BPH and CP/CPPS. Retrospective analysis of 2 clinical studies employing 6-month TT for the treatment of BPH (n = 124) and CP/CPPS (n = 45) was conducted. The efficacy of the TT with DATD was assessed using validated and widely accepted parameters. Results were compared with corresponding control groups comprising of subjects who did not receive any treatment. In BPH treatment group, urinary symptoms decreased (14.3 to 4.7) and QoL improved (3.9 to 1.39). In CP/CPPS treatment group, pain score decreased (10.3 to 3.5) and QoL improved (8.1 to 2.9). The results in the 2 treatment groups were statistically significantly better than the results obtained for the corresponding control groups (P < 0.001). Innovative TT with DATD provides an effective treatment that uniquely employs body energy for the management of BPH and CP/CPPS.
📖 Papers frequently viewed together
References55
Newest
#1Haitham Abdelmoteleb (Cardiff and Vale University Health Board)H-Index: 1
#2Martino Aiello (UniFI: University of Florence)H-Index: 1
Last. Kim Pauwaert (Ghent University Hospital)H-Index: 4
view all 13 authors...
Lower urinary tract symptoms (LUTS) are categorized according to how they relate to the storage and voiding cycle. This relationship indicates whether there is a problem when the bladder is storing urine, or whilst the bladder is emptying or straight afterwards. Even though the LUTS are grouped in this way, potential underlying mechanisms are very diverse, and the balance of symptoms can indicate causative factors. Crucially, two symptoms (nocturia and increased daytime frequency) are LUTS, but ...
Source
#1Seiji Matsumoto (Asahikawa Medical University)H-Index: 13
#2Sachiko Kasamo (Asahikawa Medical University)H-Index: 1
Last. Kazumi HashizumeH-Index: 7
view all 3 authors...
OBJECTIVES: To evaluate the short-term efficacy and safety of two α1-adrenoceptor (AR) antagonists, tamsulosin and silodosin, in treating patients with untreated lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH), with a focus on stool form. METHODS: This study was a non-blinded, open-label, prospective randomized comparative study. Tamsulosin or silodosin was administered to patients with untreated LUTS/BPH, and their efficacy and safety in the early stage of tre...
Source
#1Eric Bortnick (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 2
#2Vannita Simma-Chiang (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 3
Last. Steven A. Kaplan (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 50
view all 4 authors...
Purpose of Review Benign prostatic hyperplasia (BPH) is among the most common diseases worldwide, manifesting clinically with lower urinary tract symptoms (LUTS). The prevalence of BPH and LUTS increases with age. There has been an increase in the types of medication available for treatment. The purpose of this review is to examine the recent literature on medication for the treatment of BPH and LUTS as it relates to older adult men.
Source
Abstract Introduction The incidence of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is high. Thermobalancing therapy (TT) with Dr Allen's Therapeutic Device (DATD) improves the condition of men with CP/CPPS by treating the cause of this disease. The aim of this study is to improve management of CP/CPPS. Methods A clinical trial observed the dynamics of clinical characteristics and parameters in 45 men with CP/CPPS who used DATD, before and after a 6-month period of therapy, and in ...
Source
#1W Y Zhang (PKU: Peking University)H-Index: 4
Objective Rapid population ageing in China is increasing the prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) among older people. The associated economic burden is increasing as well. Relevant data from China are currently insufficient. Design Secondary analysis of a cohort sample. Setting A nationally representative, cross-sectional survey—the China Health and Retirement Longitudinal Study (CHARLS)—was conducted in 2011 in mainland China. Particip...
Source
#1Shinji FujiiH-Index: 3
#2Shinichi YamashitaH-Index: 14
Last. Yoichi AraiH-Index: 61
view all 13 authors...
BACKGROUND: Many elderly men suffer from benign prostatic hyperplasia (BPH). Recently, chronic ischemia in the prostate has been suggested to be related to BPH. Thus, the impact of chronic ischemia on the development of prostatic hyperplasia and the efficacy of phosphodiesterase type 5 (PDE5) inhibitor for hyperplasia were evaluated in a rat model with chronic ischemia induced by local atherosclerosis. METHODS: Eighteen male Sprague-Dawley rats were divided into three groups: sham operation, reg...
Source
INTRODUCTION: The outcomes of clinical studies show Thermobalancing therapy (TT) with Dr Allen’s Therapeutic Device (DATD) successfully helps men treat chronic prostatitis / chronic pelvic pain syndrome (CP/CPPS) and lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH). The purpose of this study is to compare the ratio of the causes of these diseases with their treatment. METHODS: Two clinical trials observed dynamics of urinary symptoms, pain score and prostate volume i...
Source
#1Simon AllenH-Index: 8
#1Rodney U. Anderson (Stanford University)H-Index: 28
#2David WiseH-Index: 9
Last. Brian H. NathansonH-Index: 31
view all 3 authors...
Abstract Objective To evaluate effectiveness of physical therapy, biofeedback, and/or cognitive behavioral therapy for chronic prostatitis/chronic pelvic pain syndrome (CP and/or CPPS). This symptom complex has resisted resolution from conventional urologic treatment of the prostate, which includes antibiotics, alpha-blockers, and analgesics. Beginning in 1995, a new paradigm was introduced viewing CP and/or CPPS as a psychoneuromuscular disorder driven by protective pelvic floor guarding and ps...
Source
#1Simon AllenH-Index: 1
Background: Innovative thermobalancing therapy (TT) with Dr Allen’s therapeutic device (DATD) treats affected organs by the energy of one’s own body. 10 years empirical evidence has shown that the use of DATD helps to recover from chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) and benign prostatic hyperplasia (BPH), and to dissolve kidney stones. Moreover, the cost of DATD compares favourably with the cost of conventional treatments. Objectives: The purpose of this study is to point ...
Source
Cited By2
Newest
Background: The choice of treatment for benign prostatic hyperplasia (BPH) and kidney stone disease (KSD) impacts the attainment of successful ageing and the level of patient care required in the long-term. Medications and surgeries typically used for these conditions have serious side effects and can interfere with healthy aging. Objectives: This study assesses the impact of Dr Allen’s Therapeutic devices (DATD) and thermobalancing therapy® (TT) on the ageing process of people with BPH and KSD....
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.